Taken together, FAAH1/FAAH2–CNR1/CNR2 genetics align with reviews positioning the ECS in obesity pathogenesis and as a therapeutic target, supporting ECS-informed precision strategies for comorbid obesity–depression [45]. This evidence concerns the gene FAAH2 and obesity disorder.